Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Starting your retirement planning now can lead to a more secure financial future. Discover the reasons to begin your journey today.
27,547 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Markets remain choppy as 2026 unfolds. This article lays out practical steps to shield portfolios and stay resilient ...
A stock trading earnings at a strikingly low multiple sits quietly in many portfolios. This article breaks down how t...
A hypothetical look at britain's warren buffett pared nearly every position in a $13 billion portfolio during the fir...
FuelCell Energy stock just dropped after a mixed Q1 2026 report. In this analysis, we break down the what, why, and w...
A triple-leveraged ETF focused on semiconductors can swing wildly. This piece breaks down why the direxion daily semi...
A stock that slid from its all-time high by more than half now leads the charge for contrarian investors. This guide ...
After a slow season, many sellers paused listings. If 75,000 relistings occur, demand could rise without a flood of n...
A major industrial player signals confidence with a $4.3 million stake move. This analysis explains what worthington ...
Broadcom stands at a pivotal crossroads as AI spending shifts from pilots to production. This article lays out the ke...
Looking for nasdaq stocks before they soar in 2026? This article uncovers two compelling growth names, the catalysts ...
The popular image of Annaly Capital focuses on its hefty dividend. But the real investment story sits in the balance ...